ALEMBIC PHARMACEUTICALS LTD. - 533573 - Clarification On Increase In Volume
Please find attached the clarification submitted by the Company.21-09-2023
ALEMBIC PHARMACEUTICALS LTD. - 533573 - Clarification On Increase In Volume
Please find attached the clarification submitted by the Company.ALEMBIC PHARMACEUTICALS LTD. - 533573 - Clarification sought from Alembic Pharmaceuticals Ltd
The Exchange has sought clarification from Alembic Pharmaceuticals Ltd on September 21, 2023, with reference to Movement in Volume.The reply is awaited.ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached the intimation for loss of Share certificateALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached the intimation of loss of Share certificatesALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached the intimation for loss of Share Certificates.ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Change in Management
Please find attached herewith the intimation pertaining to resignation of Senior management Personnel.ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find attached the intimation of loss of Share Certificate.ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Please find enclosed herewith the Intimation of Loss of Share Certificate under regulation 39(3) of SEBI LODR, 2015ALEMBIC PHARMACEUTICALS LTD. - 533573 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Kindly find attached herewith the Intimation for loss of Share Certificate.ALEMBIC PHARMACEUTICALS LTD. - 533573 - Announcement under Regulation 30 (LODR)-Change in Management
Please find attached the Intimation under Regulation 30.